Chronic constipation: improved understanding offers a new therapeutic approach.
作者信息
Sanger Gareth J
机构信息
Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
出版信息
J Physiol. 2016 Aug 1;594(15):4085-7. doi: 10.1113/JP272560.
Abstract
摘要
相似文献
1
Chronic constipation: improved understanding offers a new therapeutic approach.
J Physiol. 2016 Aug 1;594(15):4085-7. doi: 10.1113/JP272560.
2
Chronic constipation: a critical review.
Dig Liver Dis. 2013 Nov;45(11):886-93. doi: 10.1016/j.dld.2013.03.016. Epub 2013 Apr 30.
3
Prevalence and ramifications of chronic constipation.
Manag Care Interface. 2005 Aug;18(8):23-30.
4
New and emerging treatment options for chronic constipation.
Rev Gastroenterol Disord. 2004;4 Suppl 2:S43-51.
5
Current Management of Chronic Constipation in Japan.
Keio J Med. 2023 Dec 25;72(4):95-101. doi: 10.2302/kjm.2022-0036-IR. Epub 2023 Aug 22.
6
[THE ISRAELI NEUROGASTROENTEROLOGY ASSOCIATION RECOMMENDATIONS FOR THE EVALUATION AND TREATMENT OF CHRONIC CONSTIPATION].
Harefuah. 2017 Nov;156(11):725-729.
7
Chronic constipation and gut microbiota: current research insights and therapeutic implications.
Postgrad Med J. 2024 Nov 22;100(1190):890-897. doi: 10.1093/postmj/qgae112.
8
Use of macrogol 4000 in chronic constipation.
Eur Rev Med Pharmacol Sci. 2011 Aug;15(8):960-6.
9
A gap in our understanding: chronic constipation and its comorbid conditions.
Clin Gastroenterol Hepatol. 2009 Jan;7(1):9-19. doi: 10.1016/j.cgh.2008.07.005. Epub 2008 Oct 1.
10
[Chronic constipation].
Dtsch Med Wochenschr. 2024 Nov;149(22):1324-1328. doi: 10.1055/a-2194-3285. Epub 2024 Oct 22.
引用本文的文献
1
Efficacy of atypical antipsychotics in the treatment of fecal incontinence in children and adolescents: a randomized clinical trial.
BMC Pediatr. 2024 Jan 3;24(1):7. doi: 10.1186/s12887-023-04474-4.
本文引用的文献
1
Stimulation of dopamine D2-like receptors in the lumbosacral defaecation centre causes propulsive colorectal contractions in rats.
J Physiol. 2016 Aug 1;594(15):4339-50. doi: 10.1113/JP272073. Epub 2016 Apr 28.
2
Site and mechanism of the colokinetic action of the ghrelin receptor agonist, HM01.
Neurogastroenterol Motil. 2015 Dec;27(12):1764-71. doi: 10.1111/nmo.12688. Epub 2015 Sep 28.
3
Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.
Nat Rev Gastroenterol Hepatol. 2016 Jan;13(1):38-48. doi: 10.1038/nrgastro.2015.163. Epub 2015 Sep 22.
4
Colokinetic effect of noradrenaline in the spinal defecation center: implication for motility disorders.
Sci Rep. 2015 Jul 28;5:12623. doi: 10.1038/srep12623.
5
A ghrelin receptor agonist is an effective colokinetic in rats with diet-induced constipation.
Neurogastroenterol Motil. 2015 May;27(5):610-7. doi: 10.1111/nmo.12517. Epub 2015 Jan 19.
6
Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease.
Neurology. 2015 Feb 10;84(6):609-16. doi: 10.1212/WNL.0000000000001240.
7
Bias analyses of preclinical and clinical D2 dopamine ligands: studies with immediate and complex signaling pathways.
J Pharmacol Exp Ther. 2015 Mar;352(3):480-93. doi: 10.1124/jpet.114.220293. Epub 2014 Dec 24.
8
Novel dimensions of D3 receptor function: Focus on heterodimerisation, transactivation and allosteric modulation.
Eur Neuropsychopharmacol. 2015 Sep;25(9):1470-9. doi: 10.1016/j.euroneuro.2014.09.016. Epub 2014 Oct 23.
9
New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease.
Neurogastroenterol Motil. 2014 Dec;26(12):1771-82. doi: 10.1111/nmo.12459. Epub 2014 Oct 19.
10
American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome.
Gastroenterology. 2014 Nov;147(5):1149-72.e2. doi: 10.1053/j.gastro.2014.09.002. Epub 2014 Sep 16.
Zotero 插件